Access to Affordable Medication Delayed Is Health Care Denied: State Judiciary Committee Introduces CREATES Act

22 July 2016 Pharmaceutical Law & Industry Report Publication
Authors: James W. Matthews David L. Rosen Katy E. Koski

Pharmaceutical Law & Industry Report

Partners James Matthews, David Rosen and Katy Koski, along with Senior Counsel Jason Drori, contributed an article to Bloomberg BNA’s Pharmaceutical Law & Industry Report, “Access to Affordable Medication Delayed Is Health Care Denied: State Judiciary Committee Introduces CREATES Act,” on July 22, 2016. The article discussed the bill proposed by the Senate Judiciary Committee entitled the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2016, designed to focus on drug affordability and price transparency. The authors detailed regulatory background, along with reactions and implications of CREATES.

Related Services